Abstract
It has been demonstrated that high-dose methadone maintenance is efficacious in reducing cocaine abuse in opioid-dependent individuals, but it is not clear whether this is caused by an action of methadone on the direct reinforcing properties of cocaine or on cocaine seeking. Also, it is not clear whether high-dose methadone maintenance may induce behavioral side effects, which could limit its clinical use. Here, we report that high-dose methadone maintenance (20–40 mg/kg/day) does not reduce, and even enhances cocaine (10–30 mg/kg, i.p.)-induced elevation in dopamine concentration in the ventral striatum measured by in vivo microdialysis. In parallel, however, rats maintained on high-dose methadone (30 mg/kg/day) seek and consume significantly less cocaine than controls when tested for intravenous cocaine (0.5 mg/kg/infusion) self-administration on a progressive ratio schedule of reinforcement. This reduction in cocaine self-administration does not result from impaired sensory-motor functioning as rats maintained on high-dose methadone show normal locomotor activity. Furthermore, the reduction in responding for cocaine does not seem to result from general behavioral deficits as male rats maintained on high methadone doses respond normally to palatable food and thermal pain, although their sexual responses to receptive females are greatly suppressed. Taken together, these results from studies in rats support the usefulness of larger doses of methadone to reduce severe cocaine abuse in opioid-dependent individuals and possibly in the management of pure-cocaine addiction.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Adams JU, Holtzman SG (1990). Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology 100: 451–458.
Agmo A, Paredes R (1988). Opioids and sexual behavior in the male rat. Pharmacol Biochem Behav 30: 1021–1034.
Alford DP, Compton P, Samet JH (2006a). Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 144: 127–134.
Alford DP, Compton P, Samet JH (2006b). Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 144: 127–134.
Azaryan AV, Coughlin LJ, Buzas B, Clock BJ, Cox BM (1996). Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions. J Neurochem 66: 443–448.
Band LC, Hull EM (1990). Morphine and dynorphin(1–13) microinjected into the medial preoptic area and nucleus accumbens: effects on sexual behavior in male rats. Brain Res 524: 77–84.
Barr AM, Phillips AG (1999). Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology 141: 99–106.
Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D (2005). Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 90: 203–206.
Borg L, Broe DM, Ho A, Kreek MJ (1999). Cocaine abuse sharply reduced in an effective methadone maintenance program. J Addict Dis 18: 63–75.
Brown EE, Finlay JM, Wong JT, Damsma G, Fibiger HC (1991). Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256: 119–126.
Carter RB (1991). Differentiating analgesic and non-analgesic drug activities on rat hot plate: effect of behavioral endpoint. Pain 47: 211–220.
Ceccarelli I, De Padova AM, Fiorenzani P, Massafra C, Aloisi AM (2006). Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats. Neuroscience 140: 929–937.
Cicero TJ, Meyer ER, Bell RD, Koch GA (1976). Effects of morphine and methadone on serum testosterone and luteinizing hormone levels and on the secondary sex organs of the male rat. Endocrinology 98: 367–372.
Cicero TJ, Meyer ER, Wiest WG, Olney JW, Bell RD (1975). Effects of chronic morphine administration on the reproductive system of the male rat. J Pharmacol Exp Ther 192: 542–548.
Compton P, Charuvastra VC, Kintaudi K, Ling W (2000). Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage 20: 237–245.
Daniell HW (2002a). Hypogonadism in men consuming sustained-action oral opioids. J Pain 3: 377–384.
Daniell HW (2002b). Narcotic-induced hypogonadism during therapy for heroin addiction. J Addict Dis 21: 47–53.
De la Rosa RE, Hennessey JV (1996). Hypogonadism and methadone: hypothalamic hypogonadism after long-term use of high-dose methadone. Endocr Pract 2: 4–7.
Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274–5278.
Dole VP (1988). Implications of methadone maintenance for theories of narcotic addiction. JAMA 260: 3025–3029.
Doverty M, Somogyi AA, White JM, Bochner F, Beare CH, Menelaou A et al (2001a). Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 93: 155–163.
Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W (2001b). Hyperalgesic responses in methadone maintenance patients. Pain 90: 91–96.
Everitt BJ, Wolf ME (2002). Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22: 3312–3320.
Fischer B, Chin AT, Kuo I, Kirst M, Vlahov D (2002). Canadian illicit opiate users’ views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse 37: 495–522.
Floresco SB, West AR, Ash B, Moore H, Grace AA (2003). Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6: 968–973.
Foltin RW, Christiansen I, Levin FR, Fischman MW (1995). Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J Pharmacol Exp Ther 275: 38–47.
Foltin RW, Fischman MW (1996). Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther 278: 1153–1164.
Franklin KBJ, Abbott FV (1989). Techniques for assessing the effects of drugs on nociceptive responses. In: Boulton AA, Baker GB, Greenshaw AJ (eds). Neuromethods. Humana Press: New Jersey. pp 145–216.
Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M et al (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 57: 1573–1582.
Gratton A, Wise RA (1994). Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci 14: 4130–4146.
Hemby SE, Co C, Dworkin SI, Smith JE (1999). Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. J Pharmacol Exp Ther 288: 274–280.
Hummel M, Schroeder J, Liu-Chen LY, Cowan A, Unterwald EM (2006). An antisense oligodeoxynucleotide to the mu opioid receptor attenuates cocaine-induced behavioral sensitization and reward in mice. Neuroscience 142: 481–492.
Kalivas PW, Volkow N, Seamans J (2005). Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45: 647–650.
Koob GF, Bloom FE (1988). Cellular and molecular mechanisms of drug dependence. Science 242: 715–723.
Koob GF, le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97–129.
Koob GF, Nestler EJ (1997). The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9: 482–497.
Kreek MJ (2000). Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 909: 186–216.
Kreek MJ (2001). Drug addictions. Molecular and cellular endpoints. Ann NY Acad Sci 937: 27–49.
Leri F, Tremblay A, Sorge RE, Stewart J (2004). Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology 29: 1312–1320.
Leri F, Zhou Y, Goddard B, Cummins E, Kreek MJ (2006). Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain. Neuropsychopharmacology 31: 1462–1474.
Leri F, Zhou Y, Goddard B, Kreek MJ (2005). Reinstatement of conditioned reinforcing value of cocaine cues by cocaine: effects of methadone maintenance on cocaine seeking, HPA axis activity, and expression of mu-opioid receptor (MOR) mRNA in mesocorticolimbic areas. Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington, DC. No. 801.22.
Lin Y, Morrow TJ, Kiritsy-Roy JA, Terry LC, Casey KL (1989). Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia. Brain Res 479: 306–312.
Macenski MJ, Schaal DW, Cleary J, Thompson T (1994). Changes in food-maintained progressive-ratio responding of rats following chronic buprenorphine or methadone administration. Pharmacol Biochem Behav 47: 379–383.
Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE (2005). Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol 13: 293–302.
Martin TJ, Kahn W, Cannon DG, Smith JE (2006). Self-administration of heroin, cocaine and their combination under a discrete trial schedule of reinforcement in rats. Drug Alcohol Depend 82: 282–286.
Mathon DS, Lesscher HM, Gerrits MA, Kamal A, Pintar JE, Schuller AG et al (2005a). Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice. Neuroscience 130: 359–367.
Mathon DS, Ramakers GM, Pintar JE, Marinelli M (2005b). Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors. Eur J Neurosci 21: 2883–2886.
Mathon DS, Vanderschuren LJ, Ramakers GM (2006). Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of mu-opioid receptor knockout mice. Neuroscience 141: 1679–1684.
Maxwell S, Shinderman M (1999). Optimizing response to methadone maintenance treatment: use of higher-dose methadone. J Psychoactive Drugs 31: 95–102.
McMillan DE, McGivney WT, Hardwick WC (1980). Effects of drugs on behavior in rats maintained on morphine, methadone or pentobarbital. J Pharmacol Exp Ther 215: 9–14.
Mendelson SD, Pfaus JG (1989). Level searching: a new assay of sexual motivation in the male rat. Physiol Behav 45: 337–341.
Mirin SM, Meyer RE, Mendelson JH, Ellingboe J (1980). Opiate use and sexual function. Am J Psychiatry 137: 909–915.
Misra AL, Pontani RB, Vadlamani NL (1987). Stereospecific potentiation of opiate analgesia by cocaine: predominant role of noradrenaline. Pain 28: 129–138.
Mogenson GJ, Jones DL, Yim CY (1980). From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14: 69–97.
Nader MA, Thompson T (1987). Interaction of methadone, reinforcement history, and variable-interval performance. J Exp Anal Behav 48: 303–315.
Nader MA, Thompson T (1989). Interaction of reinforcement history with methadone on responding maintained under a fixed-interval schedule. Pharmacol Biochem Behav 32: 643–649.
Negus SS (2006). Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317: 711–723.
Negus SS, Mello NK (2004). Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend 74: 297–309.
Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119–128.
Paxinos G, Watson C (2005). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
Peles E, Kreek MJ, Kellogg S, Adelson M (2006a). High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis 25: 43–50.
Peles E, Schreiber S, Adelson M (2006b). Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 82: 211–217.
Pfaus JG, Gorzalka BB (1987). Opioids and sexual behavior. Neurosci Biobehav Rev 11: 1–34.
Pfaus JG, Mendelson SD, Phillips AG (1990). A correlational and factor analysis of anticipatory and consummatory measures of sexual behavior in the male rat. Psychoneuroendocrinology 15: 329–340.
Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM (2003). Subsecond dopamine release promotes cocaine seeking. Nature 422: 614–618.
Preston KL, Sullivan JT, Strain EC, Bigelow GE (1996). Enhancement of cocaine's abuse liability in methadone maintenance patients. Psychopharmacology 123: 15–25.
Pud D, Cohen D, Lawental E, Eisenberg E (2006). Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 82: 218–223.
Richardson NR, Roberts DC (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Meth 66: 1–11.
Robbins TW, Everitt BJ (2002). Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem 78: 625–636.
Robinson TE, Berridge KC (2003). Addiction. Annu Rev Psychol 13: 155–162.
Rodriguez-Manzo G, Asai M, Fernandez-Guasti A (2002). Evidence for changes in brain enkephalin contents associated to male rat sexual activity. Behav Brain Res 131: 47–55.
Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR (2005). Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry 162: 340–349.
Scimeca MM, Savage SR, Portenoy R, Lowinson J (2000). Treatment of pain in methadone-maintained patients. Mt Sinai J Med 67: 412–422.
Self DW (2004). Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47: 242–255.
Shaham Y, Hope BT (2005). The role of neuroadaptations in relapse to drug seeking. Nat Neurosci 8: 1437–1439.
Sorge RE, Rajabi H, Stewart J (2005). Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacology 30: 1681–1692.
Sorge RE, Stewart J (2006). The effects of long-term chronic buprenorphine treatment on the locomotor and nucleus accumbens dopamine response to acute heroin and cocaine in rats. Pharmacol Biochem Behav 84: 300–305.
Stewart J (2003). Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. Am J Addict 12: 1–17.
Stine SM, Burns B, Kosten T (1991). Methadone dose for cocaine abuse. Am J Psychiatry 148: 1268.
Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993). Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 119: 23–27.
Tang XC, McFarland K, Cagle S, Kalivas PW (2005). Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci 25: 4512–4520.
Tokunaga Y, Muraki T, Hosoya E (1977). Effects of repeated morphine administration on copulation and on the hypothalamic-pituitary-gonadal axis of male rats. Jpn J Pharmacol 27: 65–70.
Unterwald EM (2001). Regulation of opioid receptors by cocaine. Ann N Y Acad Sci 937: 74–92.
Unterwald EM, Horne-King J, Kreek MJ (1992). Chronic cocaine alters brain mu opioid receptors. Brain Res 584: 314–318.
Waddell AB, Holtzman SG (1999). Modulation of cocaine-induced antinociception by opioid-receptor agonists. Pharmacol Biochem Behav 62: 247–253.
Wise RA, Bozarth MA (1981). Brain substrates for reinforcement and drug self-administration. Prog Neuropsychopharmacol 5: 467–474.
Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JBJ (1995). Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 120: 10–20.
Yuferov V, Zhou Y, Spangler R, Maggos CE, Ho A, Kreek MJ (1999). Acute ‘binge’ cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system. Brain Res Bull 48: 109–112.
Zavala AR, Weber SM, Rice HJ, Alleweireldt AT, Neisewander JL (2003). Role of the prelimbic subregion of the medial prefrontal cortex in acquisition, extinction, and reinstatement of cocaine-conditioned place preference. Brain Res 990: 157–164.
Zernig G, O’Laughlin IA, Fibiger HC (1997). Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol 337: 1–10.
Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ (1996). Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 2: 1225–1229.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leri, F., Sorge, R., Cummins, E. et al. High-Dose Methadone Maintenance in Rats: Effects on Cocaine Self-Administration and Behavioral Side Effects. Neuropsychopharmacol 32, 2290–2300 (2007). https://doi.org/10.1038/sj.npp.1301357
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1301357
Keywords
This article is cited by
-
The effects of acute and chronic steady state methadone on memory retrieval in rats
Psychopharmacology (2012)
-
Episodic Withdrawal Promotes Psychomotor Sensitization to Morphine
Neuropsychopharmacology (2010)
